These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 14563893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
    Jansen J, Akard LP, Wack MF, Thompson JM, Dugan MJ, Leslie JK, Mattison R.
    Mycoses; 2006 Sep; 49(5):397-404. PubMed ID: 16922792
    [Abstract] [Full Text] [Related]

  • 3. [Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
    Miguélez M, Lumbreras C, Herrero JA, Aguado JM, del Palacio A, Colina F, Gómez R, Lizasoain M, Moreno E, Rodríguez-Noriega A.
    Med Clin (Barc); 1998 Mar 28; 110(11):406-10. PubMed ID: 9608495
    [Abstract] [Full Text] [Related]

  • 4. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL.
    Liver Transpl; 2005 Jun 28; 11(6):656-62. PubMed ID: 15915482
    [Abstract] [Full Text] [Related]

  • 5. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T, Lai WK, Gow P, Leeming J, Mutimer D.
    Transpl Infect Dis; 2005 Jun 28; 7(3-4):126-32. PubMed ID: 16390401
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K.
    Clin Infect Dis; 2009 Feb 01; 48(3):265-73. PubMed ID: 19115967
    [Abstract] [Full Text] [Related]

  • 7. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM, Solé A, de la Torre M, Pastor A, Fernandez R, Saura A, Delgado M, Monte E, Gonzalez D.
    Transplant Proc; 2008 Nov 01; 40(9):3090-3. PubMed ID: 19010204
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
    Linden PK, Coley K, Fontes P, Fung JJ, Kusne S.
    Clin Infect Dis; 2003 Jul 01; 37(1):17-25. PubMed ID: 12830404
    [Abstract] [Full Text] [Related]

  • 10. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul 01; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 11. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO, Bowman JL, Penzak SR.
    Pharmacotherapy; 1998 Jul 01; 18(3):549-64. PubMed ID: 9620106
    [Abstract] [Full Text] [Related]

  • 12. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF, Pontón C, Bustamante M, Otero E, Martínez J, Tomé S, Conde R, Segade FR, Delgado M, Brage A, Galbán C, Varo E.
    Transplant Proc; 2005 Nov 01; 37(9):3965-7. PubMed ID: 16386598
    [Abstract] [Full Text] [Related]

  • 13. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
    Husain S, Tollemar J, Dominguez EA, Baumgarten K, Humar A, Paterson DL, Wagener MM, Kusne S, Singh N.
    Transplantation; 2003 Jun 27; 75(12):2023-9. PubMed ID: 12829905
    [Abstract] [Full Text] [Related]

  • 14. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
    Watanabe N, Matsumoto K, Kojima S, Kato K.
    J Pediatr Hematol Oncol; 2011 May 27; 33(4):270-5. PubMed ID: 21464763
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A, Pfaller M, Steinbach WJ, Webster KM, Marr KA.
    Transpl Infect Dis; 2010 Jun 27; 12(3):220-9. PubMed ID: 20113459
    [Abstract] [Full Text] [Related]

  • 16. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
    Hovi L, Saxen H, Saarinen-Pihkala UM, Vettenranta K, Meri T, Richardson M.
    Pediatr Blood Cancer; 2007 Jan 27; 48(1):28-34. PubMed ID: 16395687
    [Abstract] [Full Text] [Related]

  • 17. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
    Saliba F, Delvart V, Ichaï P, Kassis N, Botterel F, Mihaila L, Azoulay D, Adam R, Castaing D, Bretagne S, Samuel D.
    Med Mycol; 2013 Feb 27; 51(2):155-63. PubMed ID: 22800082
    [Abstract] [Full Text] [Related]

  • 18. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM, Sivak O, Rosland M, Risovic V, Bartlett K.
    J Pharm Sci; 2007 Jul 27; 96(7):1737-47. PubMed ID: 17080414
    [Abstract] [Full Text] [Related]

  • 19. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
    Mehta J, Kelsey S, Chu P, Powles R, Hazel D, Riley U, Evans C, Newland A, Treleaven J, Singhal S.
    Bone Marrow Transplant; 1997 Jul 27; 20(1):39-43. PubMed ID: 9232254
    [Abstract] [Full Text] [Related]

  • 20. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
    Ho KM, Duff O, Chambers D, Murray R.
    Transpl Infect Dis; 2008 Jun 27; 10(3):168-76. PubMed ID: 18194368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.